Overview

Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori

Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
This study compared efficacy and safety of basic triple therapy including Ilaprazole 10mg, Levofloxacin 500mg and Amoxicillin 1000mg BID for 10 days on the first line eradication treatment of H.pylori
Details
Lead Sponsor:
Il-Yang Pharm. Co., Ltd.
Treatments:
Amoxicillin
Levofloxacin
Ofloxacin